Combination GLP-1 Therapy Reduces Fat Mass While Preserving Lean Muscle in Adults with Obesity
A groundbreaking clinical trial has revealed that combining the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide with bimagrumab, a monoclonal antibody ...
